A recent analysis published in the Canadian Medical Association Journal has projected a staggering increase in cancer diagnoses and fatalities in Canada, with estimates indicating over 250,000 new cases and approximately 87,900 cancer-related deaths by 2026. Notably, lung, breast, prostate, and colorectal cancers are expected to comprise nearly half of all new cases. This alarming trend is accompanied by another significant finding: young cancer survivors are at a heightened risk of developing subsequent cancers later in life.
A Growing Health Concern
The study highlights that approximately 42 per cent of Canadians will be diagnosed with cancer at some point in their lives. Contributing factors include a population growth of around 9.5 per cent from 2020 to 2025, largely driven by immigration, and an ageing demographic. By 2025, the proportion of individuals aged 65 and older is projected to reach a record high of 19.5 per cent. As the population ages, the incidence of cancer diagnoses and related fatalities is expected to rise, posing a significant economic burden on society.
Among men, prostate cancer is anticipated to be the most frequently diagnosed, accounting for 23 per cent of new cases, followed by lung (12 per cent) and colorectal cancers (11 per cent). For women, breast cancer leads the statistics at 26 per cent, followed by lung cancer (14 per cent) and colorectal cancer (9 per cent).
The Leading Causes of Cancer Death
The report also identifies the main contributors to cancer-related mortality. Lung cancer alone is expected to represent one in five cancer deaths in 2026, with projected mortality rates of 21 per cent for men and 23 per cent for women. Other notable causes of death include colorectal cancer (10 per cent), pancreatic cancer (7 per cent), and breast cancer (13 per cent).
A stark finding of the study is that, with the exception of breast and thyroid cancers, all other types are diagnosed more frequently in men than women. Furthermore, men are expected to experience higher mortality rates across nearly all cancer types, emphasising the urgent need for targeted health interventions.
Young Survivors Face Increased Risks
In a separate yet equally crucial study published in the same journal, researchers have shed light on the long-term risks faced by young cancer survivors. Led by Miranda Fidler-Benaoudia, a cancer epidemiologist from the University of Calgary, the research indicates that individuals diagnosed with cancer between the ages of 15 and 39 are twice as likely to develop a subsequent cancer compared to their peers.
Fidler-Benaoudia attributes the increased risk to the treatments administered for the initial cancer. While radiation is essential for treating primary cancers, it concurrently raises the risk of future malignancies in the irradiated body parts. Chemotherapy and certain hormone therapies are also linked to the development of subsequent cancers. This complex interplay of treatment and genetics underscores the need for ongoing monitoring and tailored care for young survivors.
Calls for Action on Cancer Screening
As cancer rates continue to surge, public health officials are advocating for urgent action. The Society of Gynecologic Oncology of Canada recently declared cervical cancer to be the fastest-rising cancer in the nation, labelling it a “silent national health crisis.” Dr. Shannon Salvador, the society’s president, has called on the federal government to implement measures to combat this growing threat.
In response, the federal government unveiled an action plan in July 2025 aimed at eradicating cervical cancer as a public health issue by 2040. Additionally, Colorectal Cancer Canada has proposed lowering the routine screening age for colorectal cancer to 45 for average-risk Canadians, a move that has already been adopted by Prince Edward Island.
Why it Matters
The projections of rising cancer cases and deaths in Canada are a stark reminder of the growing health burden facing the nation. With nearly half of all Canadians expected to receive a cancer diagnosis in their lifetime, prioritising early detection and innovative treatment approaches is essential. Furthermore, understanding the specific needs of young cancer survivors and addressing rising cancer rates in particular demographics will be crucial in shaping effective public health policies. As we move forward, the call for comprehensive screening programmes and targeted health initiatives has never been more urgent.
